ImportRefusal LogoImportRefusal

ATRIUM Innovations inc.

⚠️ Moderate Risk

FEI: 3003221709 • Quebec, Quebec • CANADA

FEI

FEI Number

3003221709

📍

Location

Quebec, Quebec

🇨🇦

Country

CANADA
🏢

Address

1405 Du Parc-Technologique Blvd, , Quebec, Quebec, Canada

Moderate Risk

FDA Import Risk Assessment

47.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

31
Total Refusals
14
Unique Violations
12/20/2017
Latest Refusal
6/20/2002
Earliest Refusal

Score Breakdown

Violation Severity
72.9×40%
Refusal Volume
55.8×30%
Recency
0.0×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

759×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

838×

NO PROCESS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the manufacturer's failure to file a scheduled process demonstrates that the product is not being manufactured under the mandatory provisions of 21 CFR Part 108 and therefore appears to have been manufactured, processed, or packed, under insanitary conditions whereby it may have been rendered injurious to health.

21203×

UNSFDIETSP

The article appears to be a dietary supplement or ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.

4823×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

4732×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

2492×

FILTHY

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

2181×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

621×

NEEDS FCE

It appears the manufacturer is not registered as a low acid canned food or acidified food manufacturer pursuant to 21 CFR 108.25(c)(1) or 108.35(c)(1).

711×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

2381×

UNSAFE ADD

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain an unsafe food additive within the meaning of section 409.

2601×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

Refusal History

DateProductViolationsDivision
12/20/2017
54FCK99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
83NO PROCESS
Division of Northern Border Imports (DNBI)
12/20/2017
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
83NO PROCESS
Division of Northern Border Imports (DNBI)
12/20/2017
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
83NO PROCESS
Division of Northern Border Imports (DNBI)
12/20/2017
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
83NO PROCESS
Division of Northern Border Imports (DNBI)
12/20/2017
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
83NO PROCESS
Division of Northern Border Imports (DNBI)
12/20/2017
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
83NO PROCESS
Division of Northern Border Imports (DNBI)
12/20/2017
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
83NO PROCESS
Division of Northern Border Imports (DNBI)
4/25/2014
20DHE99BERRY JUICE, N.E.C. BERRY JUICE OR CONCENTRATES
62NEEDS FCE
83NO PROCESS
New York District Office (NYK-DO)
6/17/2013
54ACL90MULTIPLE VITAMINS (MVI-12 VITAMIN COMBO) (VITAMIN)
2300DIETARYLBL
473LABELING
482NUTRIT LBL
New York District Office (NYK-DO)
1/7/2012
53PD99OTHER COSMETIC RAW MATERIALS, N.E.C.
471CSTIC LBLG
New Orleans District Office (NOL-DO)
1/7/2012
66VAL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/7/2012
66VAL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/7/2012
66VAL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/7/2012
66VAL99MISCELLANEOUS PATENT MEDICINES, ETC.
71NO LICENSE
New Orleans District Office (NOL-DO)
11/15/2010
54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
New York District Office (NYK-DO)
6/1/2009
54ECL29YOHIMBE (HERBAL & BOTANICAL TEAS)
2120UNSFDIETSP
New York District Office (NYK-DO)
6/1/2009
54ECL29YOHIMBE (HERBAL & BOTANICAL TEAS)
2120UNSFDIETSP
New York District Office (NYK-DO)
6/1/2009
41YHY99DIETARY CONVENTIONAL FOODS, N.E.C.
2120UNSFDIETSP
New York District Office (NYK-DO)
8/25/2008
54YCL99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
218LIST INGRE
New York District Office (NYK-DO)
7/30/2004
54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/30/2004
54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/30/2004
54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/30/2004
54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/30/2004
54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/30/2004
54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
11/13/2003
54GBZ04SHARK (ANIMAL BY-PRODUCTS AND EXTRACTS)
249FILTHY
New York District Office (NYK-DO)
6/24/2003
54FCK99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
320LACKS FIRM
482NUTRIT LBL
Cincinnati District Office (CIN-DO)
2/14/2003
54GBY04SHARK (ANIMAL BY-PRODUCTS AND EXTRACTS)
473LABELING
New York District Office (NYK-DO)
1/20/2003
54GBK01BOVINE (COW, ETC.) (ANIMAL BY-PRODUCTS AND EXTRACTS)
249FILTHY
New Orleans District Office (NOL-DO)
1/20/2003
54GBK01BOVINE (COW, ETC.) (ANIMAL BY-PRODUCTS AND EXTRACTS)
238UNSAFE ADD
New Orleans District Office (NOL-DO)
6/20/2002
54GAK04SHARK (ANIMAL BY-PRODUCTS AND EXTRACTS)
482NUTRIT LBL
New York District Office (NYK-DO)

Frequently Asked Questions

What is ATRIUM Innovations inc.'s FDA import refusal history?

ATRIUM Innovations inc. (FEI: 3003221709) has 31 FDA import refusal record(s) in our database, spanning from 6/20/2002 to 12/20/2017.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. ATRIUM Innovations inc.'s FEI number is 3003221709.

What types of violations has ATRIUM Innovations inc. received?

ATRIUM Innovations inc. has been cited for 14 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about ATRIUM Innovations inc. come from?

All FDA import refusal data for ATRIUM Innovations inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.